Long-term hormone implant therapy--hormonal and clinical effects.

PubWeight™: 1.58‹?› | Rank: Top 4%

🔗 View Article (PMID 3945443)

Published in Obstet Gynecol on March 01, 1986

Authors

D H Barlow, H I Abdalla, A D Roberts, F Al Azzawi, I Leggate, D M Hart

Articles by these authors

Alternating treatments design: one strategy for comparing the effects of two treatments in a single subject. J Appl Behav Anal (1979) 11.63

T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection. Evidence for different kinetics and recognition of a wide spectrum of protein antigens. J Immunol (1992) 5.00

Structural relationships among dimensions of the DSM-IV anxiety and mood disorders and dimensions of negative affect, positive affect, and autonomic arousal. J Abnorm Psychol (1998) 4.48

Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment. Lancet (1976) 4.24

Psychometric properties of the Depression Anxiety Stress Scales (DASS) in clinical samples. Behav Res Ther (1997) 4.00

A modern learning theory perspective on the etiology of panic disorder. Psychol Rev (2001) 3.59

Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J Immunol (1993) 3.51

The community prevalence of chronic pelvic pain in women and associated illness behaviour. Br J Gen Pract (2001) 3.48

The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology (1995) 3.45

Multicenter collaborative panic disorder severity scale. Am J Psychiatry (1997) 3.29

The development of anxiety: the role of control in the early environment. Psychol Bull (1998) 3.24

Protection from respiratory virus infections can be mediated by antigen-specific CD4(+) T cells that persist in the lungs. J Exp Med (2001) 3.19

Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis. Infect Immun (1998) 3.14

Are shame, guilt, and embarrassment distinct emotions? J Pers Soc Psychol (1996) 2.44

Psychometric properties of the Penn State Worry Questionnaire in a clinical anxiety disorders sample. Behav Res Ther (1992) 2.40

Mind the gap: Improving the dissemination of CBT. Behav Res Ther (2009) 2.35

Prevention of spinal osteoporosis in oophorectomised women. Lancet (1980) 2.34

Structural basis of capacity of lipoarabinomannan to induce secretion of tumor necrosis factor. Infect Immun (1992) 2.33

Behavioral approaches to the treatment of alcoholism. J Nerv Ment Dis (1973) 2.29

The prevalence of chronic pelvic pain in women in the United Kingdom: a systematic review. Br J Obstet Gynaecol (1998) 2.18

Single-case experimental designs. Uses in applied clinical research. Arch Gen Psychiatry (1973) 2.02

Chronic pelvic pain in the community--symptoms, investigations, and diagnoses. Am J Obstet Gynecol (2001) 2.01

Causes of sexual dysfunction: the role of anxiety and cognitive interference. J Consult Clin Psychol (1986) 1.93

Social reinforcement in the modification of agoraphobia. Arch Gen Psychiatry (1968) 1.82

Severe ovarian hyperstimulation syndrome using agonists of gonadotropin-releasing hormone for in vitro fertilization: a European series and a proposal for prevention. Fertil Steril (1990) 1.81

The minimum effective dose of estrogen for prevention of postmenopausal bone loss. Obstet Gynecol (1984) 1.80

Blood pressure measurement at screening and in general practice. Br Heart J (1977) 1.79

Oestrogen replacement therapy for prevention of osteoporosis after oophorectomy. Br Med J (1973) 1.79

Prevalence and incidence of chronic pelvic pain in primary care: evidence from a national general practice database. Br J Obstet Gynaecol (1999) 1.68

The DSM-IV field trial for mixed anxiety-depression. Am J Psychiatry (1994) 1.66

A prospective randomized single-blind comparative trial of nafarelin acetate with buserelin in long-protocol gonadotrophin-releasing hormone analogue controlled in-vitro fertilization cycles. Hum Reprod (1995) 1.61

Hormonal treatments of sexual unresponsiveness in postmenopausal women: a comparative study. Br J Obstet Gynaecol (1983) 1.60

Dioxin pollution and endometriosis in Belgium. Hum Reprod (1994) 1.59

Are shame and guilt related to distinct self-discrepancies? A test of Higgins's (1987) hypotheses. J Pers Soc Psychol (1998) 1.56

Reliability of DSM-III-R anxiety disorder categories. Using the Anxiety Disorders Interview Schedule-Revised (ADIS-R). Arch Gen Psychiatry (1993) 1.55

Comorbidity among anxiety disorders: implications for treatment and DSM-IV. J Consult Clin Psychol (1992) 1.54

Comparative effects of oestrogen and a progestogen on bone loss in postmenopausal women. Clin Sci Mol Med (1978) 1.50

Suicidal ideation and suicide attempts among patients with panic disorder: a survey of two outpatient clinics. Am J Psychiatry (1992) 1.47

A study of the experience of Glasgow women in the climacteric years. Br J Obstet Gynaecol (1989) 1.44

Is the timing of withdrawal bleeding a guide to endometrial safety during sequential oestrogen-progestagen replacement therapy? UK Continuous Combined HRT Study Investigators. Lancet (1994) 1.44

Structure of anxiety and the anxiety disorders: a hierarchical model. J Abnorm Psychol (1996) 1.44

A controlled assessment of direct intraperitoneal insemination. Fertil Steril (1992) 1.42

Effects of nadolol on arrhythmias during laparoscopy performed under general anaesthesia. Br J Anaesth (1988) 1.41

Antiendometrial antibodies in endometriosis measured by an enzyme-linked immunosorbent assay before and after treatment with danazol and nafarelin. Obstet Gynecol (1990) 1.40

A comparison of intrauterine insemination in superovulated cycles to intercourse in couples where the male is receiving steroids for the treatment of autoimmune infertility. Fertil Steril (1995) 1.39

Cardiolipin antibody levels in endometriosis and systemic lupus erythematosus. Fertil Steril (1989) 1.39

The influence of an illusion of control on panic attacks induced via inhalation of 5.5% carbon dioxide-enriched air. Arch Gen Psychiatry (1989) 1.39

Bone response to termination of oestrogen treatment. Lancet (1978) 1.38

The redistribution of body sodium in women on long-term oestrogen therapy. Clin Sci Mol Med (1974) 1.38

Effect of rifabutin on disseminated Mycobacterium avium infections in thymectomized, CD4 T-cell-deficient mice. Antimicrob Agents Chemother (1990) 1.38

Prevention of bone mineral loss in postmenopausal women by norethisterone. Obstet Gynecol (1985) 1.37

Birth weight: nature or nurture? Early Hum Dev (1995) 1.36

Old mice are able to control low-dose aerogenic infections with Mycobacterium tuberculosis. Infect Immun (1995) 1.36

Capacity of Mycobacterium avium isolates to grow well or poorly in murine macrophages resides in their ability to induce secretion of tumor necrosis factor. Infect Immun (1992) 1.36

Instructions and reinforcement in the modification of neurotic behavior. Am J Psychiatry (1969) 1.30

Dissemination of enteric Mycobacterium avium infections in mice rendered immunodeficient by thymectomy and CD4 depletion or by prior infection with murine AIDS retroviruses. Infect Immun (1992) 1.29

The structure of negative emotions in a clinical sample of children and adolescents. J Abnorm Psychol (1998) 1.29

Diagnostic comorbidity in panic disorder: effect on treatment outcome and course of comorbid diagnoses following treatment. J Consult Clin Psychol (1995) 1.29

Anxiety sensitivity, panic, and depressed mood: a reanalysis teasing apart the contributions of the two levels in the hierarchial structure of the Anxiety Sensitivity Index. J Abnorm Psychol (2001) 1.29

Hippocampal lesions disrupt navigation based on cognitive maps but not heading vectors. Nature (1998) 1.29

Behavior modification of anorexia nervosa. Arch Gen Psychiatry (1974) 1.27

Assessment instrument for panic disorder that includes fear of sensation-producing activities: the Albany Panic and Phobia Questionnaire. Anxiety (1997) 1.26

Relaxation in systematic desensitization. Arch Gen Psychiatry (1971) 1.25

Growth hormone facilitates ovulation induction by gonadotrophins. Clin Endocrinol (Oxf) (1988) 1.25

Reliability of DSM-III anxiety disorder categories using a new structured interview. Arch Gen Psychiatry (1983) 1.25

Prospective double-blind trial of synthetic steroid (Org OD 14) for preventing postmenopausal osteoporosis. Br Med J (1980) 1.24

On the relation of clinical research to clinical practice: current issues, new directions. J Consult Clin Psychol (1981) 1.23

Response to hyperventilation and inhalation of 5.5% carbon dioxide-enriched air across the DSM-III-R anxiety disorders. J Abnorm Psychol (1992) 1.22

Assessment of worry in children and adolescents: an adaptation of the Penn State Worry Questionnaire. Behav Res Ther (1997) 1.22

Metabolism of pyruvate and glucose by intact cells of Helicobacter pylori studied by 13C NMR spectroscopy. Microbiology (1994) 1.18

Effective treatment of subfertility: introducing the Cochrane Menstrual Disorders and Subfertility Group. Hum Reprod (1999) 1.18

Osteoporosis after oophorectomy for non-malignant disease in premenopausal women. Br Med J (1973) 1.17

Laparoscopic surgery for subfertility associated with endometriosis. Cochrane Database Syst Rev (2002) 1.16

The empirical basis of generalized anxiety disorder. Am J Psychiatry (1994) 1.15

Live high:train low increases muscle buffer capacity and submaximal cycling efficiency. Acta Physiol Scand (2001) 1.13

Syphilitic hepatitis in HIV-infected patients: a report of 7 cases and review of the literature. Clin Infect Dis (2004) 1.13

Long-term outcome in cognitive-behavioral treatment of panic disorder: clinical predictors and alternative strategies for assessment. J Consult Clin Psychol (1995) 1.13

Endometriosis in monozygotic twins. Fertil Steril (1997) 1.13

Evidence for a defective accumulation of protective T cells in old mice infected with Mycobacterium tuberculosis. Cell Immunol (1993) 1.11

Panic induction via inhalation of 5.5% CO2 enriched air: a single subject analysis of psychological and physiological effects. Behav Res Ther (1988) 1.11

Human blastocyst grading: an indicator of developmental potential? Hum Reprod (1993) 1.10

Syndrome comorbidity in patients diagnosed with a DSM-III-R anxiety disorder. J Abnorm Psychol (1990) 1.10

The placental transfer of propylthiouracil, methimazole and carbimazole. J Clin Endocrinol Metab (1977) 1.10

Temporal and spatial regulation of expression of heparin-binding epidermal growth factor-like growth factor in the human endometrium: a possible role in blastocyst implantation. Dev Genet (1997) 1.09

Alcoholism studies. Science (1983) 1.09

Inguinal ovary and fallopian tube--an unusual hernia. Int J Gynaecol Obstet (1988) 1.09

Endometriotic disease: the role of peritoneal fluid. Hum Reprod Update (1999) 1.08

The EMAS 2008 update on clinical recommendations on postmenopausal hormone replacement therapy. Maturitas (2008) 1.07

Identifying specific erotic cues in sexual deviations by audiotaped descriptions. J Appl Behav Anal (1975) 1.07

Disruption of the cellular inflammatory response to Listeria monocytogenes infection in mice with disruptions in targeted genes. Infect Immun (1998) 1.07

Heparin-binding epidermal growth factor significantly improves human blastocyst development and hatching in serum-free medium. Hum Reprod (1998) 1.07

Successful pregnancy outcome in a renal transplant patient following in-vitro fertilization. Hum Reprod (1995) 1.07

Pretreatment patient factors predicting attrition from a multicenter randomized controlled treatment study for panic disorder. Compr Psychiatry (1999) 1.06

Evaluation of the ratings comprising the associated symptom criterion of DSM-III-R generalized anxiety disorder. J Nerv Ment Dis (1993) 1.05

Effects of tibolone on serum lipoprotein and apolipoprotein levels compared with a cyclical estrogen/progestogen regimen. Menopause (1999) 1.05

Experimental control of sexual deviation through manipulation of the noxious scene in covert sensitization. J Abnorm Psychol (1969) 1.04

FluoroDOPA PET shows the nondopaminergic as well as dopaminergic destinations of levodopa. Neurology (1999) 1.04

A comparison of alprazolam and behavior therapy in treatment of panic disorder. J Consult Clin Psychol (1990) 1.04